Rich Receives DOD Funding to Develop Plasma Substitute

November 17, 2011 - The Department of Defense has awarded Entegrion, of which Dr. Preston Rich is Vice President and Chief Medical Officer, $43.7 million to develop a plasma-derived drug that may someday be a substitute for fresh frozen plasma.

Dr. Preston Rich, MD, MBA, FACS, and professoro in Critical Care

Preston "Chip" Rich, MD, MBA, FACS, is Associate Professor of Surgery and Chief of the Division of Trauma/Critical Care.

To read more, see this press release from UNC Health Care, or Entegrion's news release.

Upcoming Events: Education Committee Meeting 4050 Burnett-Womack,
2012-06-05; Colin G. Thomas Lectureship Old Clinic Auditorium,
2012-06-13; Nathan A. Womack Surgical Society Meeting G-100 Bondurant Hall,
2012-06-15; Softball: UNC Surgery vs. Duke Surgery ,
2012-06-16; more events…

News: Montgomery Appointed New SICU Director 2012-05-24; Four Surgeons Among First "Meaningful Users" 2012-05-24; Dehmer Article Cited by Medscape Surgery 2012-05-17; Academy of Educators Announces Surgery Inductees 2012-05-16; Demore published in latest ASCO Post 2012-05-01; More news…

Sections

Rich Receives DOD Funding to Develop Plasma Substitute